Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220009398 220003818 1.54 64.5 Palliative (P) 2016-07-29 2016-07-30 FCiSt N N 220036556 DABRAFENIB + TRAMETINIB
220009399 220003818 1.56 61 Palliative (P) 2017-05-19 2017-10-06 Capecitabine + Cisplatin + RT 2 null 220036556 AFATINIB
220009400 220021341 0 0 null 2016-01-09 2016-01-15 Bortezomib +/- Dexamethasone N N 220036564 CARBOPLATIN + PEMETREXED
220009401 220021341 0 56 Palliative (P) 2014-01-12 2014-01-12 Carboplatin+Fluorouracil 4 or 5 day 02 N 220036564 GEMTUZUMAB OZOGAMICIN
220009402 220022037 1.74 60.5 Curative (C) 2018-02-11 2018-02-25 ALL UKALL2011 IndB Std Dex (PegAsp) 02 N 220036566 METHOTREXATE INTRATHECAL
220009403 220003819 null 33.7 null 2014-05-13 2014-05-14 BOSUTINIB N N 220036569 BORTEZOMIB
220009404 220003820 null null Curative (C) 2014-03-21 2014-03-21 FEC 60 or 75 N N 220036573 CYTARABINE + ETOPOSIDE + IDARUBICIN
220009405 220003821 1.7 55.6 Curative (C) 2013-11-20 2013-11-21 THALIDOMIDE N N 220036575 CISPLATIN
220009406 220003822 1.67 78 Curative (C) 2017-01-25 2017-01-25 UKALL14- Ph 1 Induction 2 N 220036577 IDARUBICIN
220009407 220003823 null null Curative (C) null 2014-11-21 FEC Y N 220036582 FLUDARABINE + MELPHALAN
220009408 220003824 1.69 70.7 Palliative (P) 2013-06-05 2013-06-20 Cisplatin + Pemetrexed N N 220036583 RUXOLITINIB
220009409 220012058 1.6 8.7 Adjuvant (A) null 2015-04-11 IDARUBICIN N N 220036586 CISPLATIN + FLUOROURACIL
220009410 220012058 1.9 69.5 Disease modification (D) 2016-03-07 2016-03-07 CYCLOPHOSPHAMIDE + FLUDARABINE 02 N 220036586 IPILIMUMAB
220009411 220012058 1.5 69 Curative (C) null 2014-09-20 CYCLOPHOSPHAMIDE + FLUDARABINE N N 220036586 CYTARABINE + MITOXANTRONE
220009412 220020534 1.81 57.9 Palliative (P) 2015-10-20 2015-10-23 Alemtuzumab(INTRAVENOUS) 01 N 220036594 IPILIMUMAB
220009413 220020534 null null Palliative (P) 2017-09-24 2017-10-03 BOSUTINIB N N 220036594 VE
220009414 220003825 null 104 Palliative (P) 2014-03-26 2014-03-28 Cisplatin +Fluorouracil (3 wk) null null 220036603 CISPLATIN + ETOPOSIDE
220009415 220012059 null 123 Curative (C) 2017-11-02 2017-11-04 Alemtuzumab cond (RI ALLO CAMP100) 02 N 220036604 CYCLOPHOSPHAMIDE
220009416 220012059 null null Curative (C) 2013-09-19 2013-09-30 Irinotecan + Modified De Gramont N N 220036604 CISPLATIN
220009418 220020535 1.7 105 Palliative (P) 2015-03-09 2015-03-09 Methotrexate intrathecal Y N 220036609 IPILIMUMAB + NIVOLUMAB
220009419 220003826 1.77 58 Palliative (P) 2016-07-09 2016-07-18 Capecitabine + Streptozocin 2 N 220036610 LI-1 TRIAL
220009420 220012060 null null null 2013-12-05 2013-12-13 Irinotecan + Modified De Gramont N null 220036611 DACARBAZINE
220009421 220012060 1.52 6.9 Palliative (P) 2015-10-03 2015-10-08 Cyclophosphamide + Docetaxel N N 220036611 CAPECITABINE
220009422 220012060 1.59 null Adjuvant (A) null 2012-05-01 Methotrexate High Dose (3g/m2) null null 220036611 FCR
220009423 220003827 1.9 0 Disease modification (D) 2017-11-24 2017-11-26 IDARUBICIN + MITOXANTRONE + Tretinoin N N 220036620 DABRAFENIB + TRAMETINIB
220009424 220012061 1.79 null null null 2016-08-23 ALL UKALL60+ TRIAL null null 220036624 FCR
220009425 220003828 0 0 Curative (C) 2014-11-02 2014-11-02 Irinotecan + Modified De Gramont 02 Y 220036625 BOSUTINIB
220009426 220003828 null null null 2014-07-06 2014-07-12 Fludarabine + Melphalan RIC Allo N N 220036625 ALEMTUZUMAB
220009427 220016521 1.58 66.2 Curative (C) 2017-04-05 2017-05-16 LIPOSOMAL DOXORUBICIN N N 220036629 ALEMTUZUMAB
220009428 220003829 1.68 85.5 Curative (C) 2014-09-28 2014-09-29 CAPECITABINE + EPIRUBICIN + OXALIPLATIN 2 N 220036632 DOXORUBICIN
220009429 220003830 1.66 54 Not known (9) 2016-10-07 2016-10-13 OCTREOTIDE Y N 220036633 CISPLATIN + DOCETAXEL + FLUOROURACIL
220009430 220003831 1.56 51.9 Disease modification (D) 2015-06-24 2015-06-24 Cisplatin + Pemetrexed 02 N 220036637 LENALIDOMIDE
220009431 220003831 1.79 null Curative (C) 2015-11-29 2015-12-21 ETOPOSIDE + IFOSFAMIDE N N 220036637 FLUDARABINE + MELPHALAN
220009432 220003832 null 101.6 Curative (C) 2015-05-06 2015-05-25 LANREOTIDE 2 N 220036640 CISPLATIN + DOCETAXEL + FLUOROURACIL
220009433 220003832 null 86.2 null 2014-04-14 2014-05-14 IPILIMUMAB + NIVOLUMAB N N 220036640 FLUDARABINE + MELPHALAN
220009434 220003833 1.69 53.5 Not known (9) 2018-01-27 2018-01-31 Cytarabine intrathecal N N 220036645 CLOFARABINE + CYTARABINE
220009435 220003834 1.65 80.1 Palliative (P) 2017-03-27 2017-04-03 Bortezomib +/- Dexamethasone N N 220036646 LENALIDOMIDE
220009436 220003835 null 97 null 2013-12-04 2013-12-04 Mitoxantrone 2 N 220036648 CYCLOPHOSPHAMIDE + FLUDARABINE
220009437 220003836 1.49 0 Disease modification (D) 2017-01-30 2017-01-31 Dacarbazine N N 220036649 RUXOLITINIB
220009438 220003837 null 82.4 Palliative (P) 2017-01-06 2017-01-09 ECarboX null null 220036653 CETUXIMAB + IRINOTECAN + MDG
220009439 220003838 null 80 Curative (C) 2015-01-06 2015-01-22 Dacarbazine N N 220036654 CYTARABINE + DAUNORUBICIN + ETOPOSIDE
220009440 220003839 1.61 68 Adjuvant (A) 2015-01-21 2015-01-29 CYTARABINE + MITOXANTRONE N N 220036655 CISPLATIN + PEMETREXED
220009441 220003839 1.58 64.5 Curative (C) 2016-12-23 2016-12-28 BUSULFAN + FLUDARABINE + METHOTREXATE N N 220036655 IDARUBICIN + MITOXANTRONE + TRETINOIN
220009442 220003839 null 0 Curative (C) 2017-12-21 2017-12-21 UKALL 14 TRIAL N N 220036655 ARSENIC TRIOXIDE + ATRA
220009443 220003839 1.76 53 Curative (C) 2017-09-27 2017-10-15 Capecitabine N N 220036655 CETUXIMAB + RT
220009444 220003839 1.81 0 Palliative (P) 2016-05-25 2016-05-25 Capecitabine N N 220036655 VEMURAFENIB
220009446 220012066 1.69 null null 2016-06-02 2016-06-03 LANREOTIDE 99 N 220036669 OCTREOTIDE
220009447 220012066 1.59 65 Curative (C) 2015-05-03 2015-05-16 FEC N N 220036669 ARSENIC TRIOXIDE + TRETINOIN
220009448 220003841 1.58 48.2 null 2013-12-03 2014-01-07 Methotrexate High Dose (3g/m2) N N 220036673 DOCETAXEL
220009449 220012067 1.77 77.5 Curative (C) 2017-10-31 2017-11-01 Cisplatin + Pemetrexed N N 220036675 ALEMTUZUMAB + BUSULFAN + CYCLOPHOSPHAMIDE